A team-based blood pressure intervention delivered through primary care reduced dementia risk by 15% over 7 years.
Commentary|Videos|September 25, 2023
That Patient with Neck Pain in Exam Rm 2 May not Need a Neurology Referral Today
Author(s)Atul Patel, MD
The patient with neck pain might be better off referred to a physiatrist for additional evaluation and possibly treatment, according to PM&R physician Atul Patel, MD.
Advertisement
Physiatrist Atul Patel, MD, practices physical medicine and rehabilitation at the Kansas City Bone & Joint Clinic where his role and referrals to him are always evolving, he says. The number of community neurologists who rely on him to help manage spasticity in their patients with multiple sclerosis is rising steadily, for example.
When it comes to seeing patients referred by primary care, Patel points out that the frontline clinicians are typically so busy that referring a patient to a specialist, eg, a neurosurgeon or orthopedic surgeon, for a painful condition, may be the first next step that comes to mind. And often, it's the right move at the right time. In other instances, an intermediate step might be more profitable, at least in terms of time, for the patient, the specialist, and the referring primary clinician. He explains more in this conversation with Patient Care senior editor Grace Halsey.
Atul Patel, MD, is a physiatrist and current treasurer of the Board of Governors of the American Academy of Physical Medicine and Rehabilitation. Before joining the Kansas City Bone and Joint Clinic, he was an associate professor in the department of rehabilitation medicine at the University of Kansas School of Medicine. Patel's clinical areas of interest include musculoskeletal medicine, neuropathic pain, spasticity, Parkinson’s disease and dystonias, stroke rehabilitation, multiple sclerosis, nerve and muscle diseases, geriatrics, electrodiagnostic medicine and general rehabilitation medicine.
Advertisement
Related to this article
Physical activity was associated with up to 22% lower mortality and 19% lower stroke risk in adults with and without atrial fibrillation in a large Norwegian cohort study.
Plasma p-tau217 levels helped estimate 5- and 10-year cognitive impairment risk in older adults without memory or thinking symptoms.
FDA cleared C2N’s PrecivityAD2 blood test to aid Alzheimer disease evaluation in symptomatic adults aged 40 years and older.
A Swedish observational study linked NOAC use to slower cognitive decline in individuals with atrial fibrillation and Alzheimer disease.
The FDA approved oveporexton for narcolepsy type 1 in adults, marking the first orexin receptor agonist targeting the underlying biological cause of narcolepsy.
New American Society of Hematology guidelines raise ferritin cutoffs to catch iron deficiency sooner, including pregnancy and inflammation, and add TSAT for clearer diagnosis.
The US FDA cleared a novel insulin patch pump that can be used for up to 3 days with an additional 12-hour grace period in persons with diabetes.
Advertisement
Advertisement
Trending on Patient Care Online
1
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
2
Elevated PSA in Primary Care: What to Consider Before Biopsy
3
FDA Grants Priority Review to Zasocitinib for Plaque Psoriasis
4
FDA Clears Beta Bionics’ Mint Reusable Insulin Patch Pump
5